In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

I n an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top executives met, like they had dozens of times before, to hear the ...

Eli Lilly reported positive results from Phase 3 ACHIEVE-1 trial of orforglipron for type 2 diabetes, meeting primary endpoint of A1C reduction. Analysts see potential for sales of $10 billion by ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few years, though they do have some drawbacks.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks ...

But Eli Lilly says they didn’t see any signs of liver injury in the trial, unlike what happened with Pfizer’s pill. As for the only GLP-1 pill on the market, it’s called Rybelsus.

Some of the potential iterations of delivery methods Eli Lilly considered for orforglipron, at Eli Lilly’s headquarters in Indianapolis on March 31. The ultimate form has yet to be finalized.

American pharmaceutical company Eli Lilly and Company this week announced results from a late-stage clinical trial for its oral diabetes medicine, orforglipron. The once-daily pill, currently ...

By Jen Christensen, CNN (CNN) — Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...